Also trades as: 0460.HK (HKSE) · $vol 3M
SHPHF OTC
Sihuan Pharmaceutical Holdings Group Ltd.
1W: +0.0%
1M: +0.0%
3M: -7.5%
YTD: -25.0%
1Y: +21.7%
3Y: +58.7%
5Y: -41.4%
$0.12
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$244M
+22.3% ▲
5Y CAGR: -29.7%
Capital Expenditures
$186M
+36.9% ▲
5Y CAGR: -17.9%
Free Cash Flow
$58M
+160.0% ▲
5Y CAGR: -42.5%
Dividends Paid
$177M
+40.7% ▲
Buybacks
$20M
+40.0% ▲
Net Change in Cash
-$256M
-410.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $473M | $417M | -$1.9B | -$161M | -$428M |
| Depreciation & Amort. | $252M | $279M | $339M | $226M | $258M |
| Stock-Based Comp. | $23M | $59M | $90M | $89M | $418M |
| Change in Working Capital | -$335M | -$472M | -$224M | $111M | -$14M |
| Other Non-Cash Items | -$499M | -$30M | $1.6B | -$66M | $9M |
| Operating Cash Flow | $227M | $665M | $46M | $199M | $244M |
| — Investing Activities — | |||||
| Capital Expenditures | -$507M | -$601M | -$402M | -$125M | -$71M |
| Acquisitions (Net) | $14M | -$153M | $88M | $15M | $35M |
| Investment Purchases | -$18.8B | -$20.0B | -$16.2B | -$10.1B | -$9.1B |
| Investment Sales | $18.6B | $20.2B | $15.5B | $10.5B | $9.6B |
| Other Investing | -$219M | $266M | -$635M | -$96M | $267M |
| Investing Cash Flow | -$925M | -$338M | -$1.7B | $170M | $758M |
| — Financing Activities — | |||||
| Net Debt Issuance | $727M | $294M | $165M | -$31M | -$291M |
| Stock Repurchased | $0 | -$206M | $0 | -$34M | -$20M |
| Dividends Paid | -$1.4B | -$123M | -$1.3B | -$299M | -$177M |
| Other Financing | $877M | $786M | $912M | -$56M | -$770M |
| Financing Cash Flow | $185M | $751M | -$239M | -$420M | -$1.3B |
| Net Change in Cash | -$513M | $1.1B | -$1.9B | -$50M | -$256M |
| Cash End of Period | $4.6B | $5.7B | $3.8B | $3.8B | $3.5B |
| Free Cash Flow | -$280M | $64M | -$356M | -$96M | $58M |